Search results :

Carvedilol

More information: STITCH, PubChem and possibly Wikipedia

ATC Code: C07AG02

Side effects

Options: Show MedDRA Preferred Terms,   display all 39 labels

Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
Fatigue 0.7% - 24% 0.7% - 22.4% x x x x x x x x x x x x x x x x x x x x
Upper respiratory tract infection 0.1% - 18.3% 12.6% - 17.6% x x x x x
Chest pain 0.1% - 14.4% 7.6% - 14.2% x x x x x
Dyspnoea 0.5% - 21.3% 0.3% - 11% x x x
Asthenia 0.4% - 11% 0.7% - 9.4% x x x x x x x x x x x x x x
Weight increased 0.1% - 12% 0.1% - 11% x x x x x x x x x x x x x x
Hypotension 0.4% - 14% 0.2% - 8.2% x x x x x x x x x x x x x x x x x x x x
Pain 7.6% - 8.6% 0.2% - 7.6% x x x x x
Presyncope 5% - 7.6% 5% x x x
Abdominal pain 0.3% - 7.2% 3% - 7.1% x x x x x
Arthralgia 1% - 6.4% 1% - 5% x x x x x x
Dizziness 0.4% - 32.4% 0.6% - 19.2% x x x x x x x x x x x x x x x x x x x x
Vomiting 0.1% - 6.3% 2% - 4.3% x x x x x x x
Blood urea increased 0.3% - 6% 0.2% - 5% x x x x x x x x x x x x x x x x x x x x
NPN increased 0.3% - 6% 0.2% - 5% x x x x x x x
Cardiac failure 2.9% - 31.5% 31.5% x x x
Sinusitis 1.6% - 5.4% 1.1% - 4.3% x x x x x
Bronchitis 0.1% - 5.4% 0.2% - 4.5% x x x x x
Drug level increased 3.7% - 5.1% 0.2% - 3.7% x x x x x
Generalised oedema 0.2% - 6% 0.2% - 5% x x x x x x x
Headache 0.3% - 8.1% 0.1% - 7.1% x x x x x x x
Hyperglycaemia 0% - 12.2% 0.1% - 8% x x x x x x x x x x x x x x
Cough increased 0.1% - 8% 0.2% - 9% x x x x x x x
Abnormal vision 0.1% - 5% 1.8% - 2% x x x x x x x
Hypocholesterolaemia 4.1% 2.5% x
Hypercholesterolaemia 1% - 4.1% 1% - 3% x x x x x x
Lung disorder 0.1% - 4% 3.2% x x x x x
Nasopharyngitis 4% 0%
Nausea 2% - 9% 0% - 5% x x x x x x x
Rales 4% 2% - 4% x x
Gravitational oedema 3.7% - 4% 1.8% - 2% x x x x x x
Sudden death 1.3% - 6.1% 1.1% - 6.1% x x x x x
Oedema 0.2% - 5.1% 0.2% - 2.5% x x x x x
Gout 2.7% - 6.3% 2.7% - 6.2% x x x x x x x x x x x x x x x x x x x x
Pulmonary oedema 3.5% - 4.1% 4.1% x x x x x x x x x x x x x x x x x x x x
Digoxin level increased 2% - 5% 1% - 4% x x
Myalgia 3.4% 2.7% x x x x x
Hyperkalaemia 0.2% - 3.3% 0.1% - 1.9% x x x x x x x x
Pneumonia 3.2% - 3.9% 3.9% x x x x x
Body temperature increased 2.3% - 3.1% 2.3% x x x x x x x x
Pharyngitis 3.1% 2.7% x x x x x
Urinary tract infection 1.6% - 3.1% 2.4% - 2.7% x x x x x
Angina pectoris 0.1% - 6% 0.1% - 4.1% x x x x x x x
Back pain 1.4% - 6.9% 1.4% - 6.6% x x x x x
Haematuria 2.9% 2.1% x x x x x x x x
Creatinine increased 1.4% - 2.9% 0.1% - 1.4% x x x x x x x
Sweating increased 2.9% 2.1% x x x x x x x x x x x x x x x x x x x x
Vision blurred 0.2% - 2.8% 0.1% - 2.2% x x x x x x x x
Hypertension 0.1% - 2.9% 0.1% - 2.5% x x x
Hypokalaemia 2.5% - 3.4% 3.4% x x x x x x x x x x x x x x x x x x x x
Anaemia 2% - 2.4% 2% x x x x x x x x x x x x x x x x x x x x
Infection 2.2% - 2.5% 0.9% - 2.4% x x x x x
Atrioventricular block first degree 1.6% - 2.3% 1.6% x x x
Atrial fibrillation 2.2% - 4.3% 4.3% x x x x x
Leg edema 0.1% - 2.2% 0.2% x x x x x x x
Dehydration 2.1% 1.6% x x x x x
Pain in extremity 2.1% - 2.5% 2.5% x x x
Angina unstable 2% - 2.7% 2.7% x x x x
Diabetes mellitus postmarketing, 1.7% - 2% 1.7% x x x x x x x x
Diarrhoea 0.3% - 12% 0% - 6% x x x x x x x x x x x x x x x x x x
Orthostatic hypotension 0.1% - 2% 0.1% - 1% x x x x x x x x x x x x x x x x x x x x
Cramp muscle 1.2% - 2% 1.2% x x x x x x
Angina pectoris aggravated 2% 1.1% x x x x x x x
Bradycardia 0.6% - 10.3% 0.9% - 3% x x x x x x x x x x x x x x x x x x
Insomnia 1% - 2% 0% - 1% x x x x x x x x x x x x x x x x x x
Fluid overload 1.7% - 2% 0.9% - 1.6% x x x x x x x x
Syncope 0.3% - 8% 0.2% - 5% x x x x x x x
Hyperuricaemia 1.8% 1.6% x x x x x x x x
Hypoaesthesia 1.7% 1.1% x x x x x
Paraesthesia 0.1% - 2% 0% - 1.8% x x x x x x x x
Sinus bradycardia 1.7% 0.4% x x
Accidental injury 1.7% 2% x x
Kidney function abnormal 0.3% - 2.3% 1.4% - 2.3% x x x x x
Erectile dysfunction 1.7% 0.9% x x x x x x x x
Albuminuria 1.6% 1.1% x x x x x x x x
Palpitations 1.6% 0.1% - 1.5% x x x x x x x x
Ventricular tachycardia 1.6% - 3.9% 3.9% x x x x x
Peripheral vascular disorder 1.6% - 2.4% 2.4% x x x x x x x x x x x x x x x x x x x x
Melaena 1.4% 1.1% x x x x x x x x
Vertigo 1.4% 1.1% x x x x x x x x
Weight decreased 1.4% 1.1% x x x x x
Alanine aminotransferase increased 1.4% 0.9% x x x x x x x x
Confusional state 1.3% 0.9% x x
Hyponatraemia 1.3% 1.1% x x x x x x x x
Periodontitis 1.3% 0.7% x x x x x x x x
Purpura 1.3% 0.2% x x x x x x x x
Malaise 1.3% 0.7% x x x x x x x x
Prothrombin level decreased 1.3% 1.1% x x x x x x x x
Glycosuria 1.2% 0.7% x x x x x x x x
Aspartate aminotransferase increased 1.2% 0.9% x x x x x
Hypovolaemia 1.2% 0.2% x x x x x x x x
Somnolence 1.2% 0.2% - 0.9% x x x x x x x x
Hypertriglyceridaemia 1% x x x x x x x x x x x x x x x x x x x x
Nasal congestion 1% 0%
Thrombocytopenia 0.1% - 2% 0.5% x x x x x x x x x x x x x x x x x x x
Ventricular fibrillation 1% - 2.1% 2.1% x x x
Oedema peripheral 0.2% - 7% 0.1% - 6.4% x x x x x x x x x x x x x x x x x x
Sinus congestion 1% 0%
Myocardial infarction 0.9% - 2.2% 2.2% x x x
Gastrointestinal disorder 0.1% - 1.6% 0.1% - 1.1% x x
Hypoglycaemia 0.1% - 1.6% 1.4% x x x x x x x x
Renal failure 0.1% - 1.6% 1.3% x x
Renal failure acute 0.3% - 1.2% 0.5% x x
Atrioventricular block 0.5% - 2.9% 0.5% x x x x x x x x
Alopecia postmarketing x x x x x x x x x x x x x x x x x x x x
Anaphylactic shock postmarketing x x x x x x x x x x x x x x
Aplastic anaemia postmarketing x x x x x x x x x x x x x x x x x x
Angioedema postmarketing x x x x x x x x x x x x x x
Toxic epidermal necrolysis postmarketing x x x x x x x x x x x x x x x x
Erythema multiforme postmarketing x x x x x x x x x x x x x x x x
Hypersensitivity postmarketing, 1.4% 0.2% x x x x x x x x x x x x x x x x x x x
Immune system disorder postmarketing x x x x x x x
Mediastinal disorder postmarketing x x x x x x x
Stevens-Johnson syndrome postmarketing x x x x x x x x x x x x x x x x
Urinary incontinence postmarketing x x x x x x x x x x x x x x x x x x
Urinary tract disorder postmarketing x x x x x x x x x
Urticaria postmarketing x x x x x x x x x x x x x x
Malnutrition postmarketing x x
Unspecified disorder of skin and subcutaneous tissue postmarketing x x x x x x x x x
Interstitial pneumonia postmarketing x x x x x x x x x x x x x x x
Glucose tolerance impaired postmarketing x x
Blood and lymphatic system disorders postmarketing x x x x x x x
Respiratory alkalosis x x x x x x x x x x x x x x x x x x x x
Amnesia x x x x x x x x x x x x x x x x x x x x
Anorexia x x x x x
Arthritis x x x x x x x x x x x x x x x x x x x x
Clotting x x x
Breast feeding
Bronchospasm x x x x x x x x x x x x x x x x x x x x
Bundle branch block x x x x x x x x x x x x x x x x x x x x
Cardiovascular disorder x x x
Cerebrovascular disorder x x x x x x x x x x x x x x x x x x x x
Constipation
Cough x x x x x
Libido decreased x x x x x x x x x x x x x x x x x x x x
Dermatitis exfoliative x x x x x x x x x x x x x x x x x x x x
Dyspepsia x x x x x
Rash x x x x x
Flatulence x x x x x
Gastrointestinal haemorrhage x x x x x x x x x x x x x x x x x x x x
Partial hearing loss x x x x x x x x x x x x x x x x x x x x
Cardiac arrest x
Haemorrhage x x x
Hyperbilirubinaemia x x x x x x x x x x x x x x x x x x x x
Hyperaesthesia x x x
Influenza x x x x x x x x x x x x x x x
Cramps of lower extremities x x x x x
Leukopenia x x x x x x x x x x x x x x x x x x x
Hypotonia x x x x x x x x x x x x x x x
Nervousness x x x x x x x x x x x x x x x
Neuralgia x x x x x x x x x x x x x x x x x x x x
Nightmare x x x x x x x x x x x x x x x x x
Pancytopenia x x x x x x x x x x x x x x x x x x x x
Paresis x x x x x x x x x x x x x x x x x x x x
Pruritus x x x x x x x x x x x x x x x x x x x x
Psoriasis
Renal artery stenosis x x
Rhinitis x x x x x
Convulsion x x x x x x x x x x x x x x x x x x x x
Shock x
Cardiogenic shock x
Sleep disturbance
Muscle spasms
Cerebrovascular accident x x x x x x x x x x x x x x x
Swelling
Tachycardia x x x x x x x x x x x x x x x x x x x x
Tinnitus x x x x x x x x x x x x x x x x x x x x
Pollakiuria x x x x x x x x x x x x x x x x x x x x
Angiopathy x x
Viral infection x x x x x
Wheezing
Dry mouth x x x x x x x x x x x x x x x x x x x x
Mood swings x x x x x x x x x x x x x x x x x x x x
Hypokinesia x x x x x x x x x x x x x x x x x x x x
Migraine x x x x x x x x x x x x x x x x x x x x
Atrioventricular block complete x x x x x x x x x x x x x x x x x x x x
Gamma-glutamyltransferase increased x x x x
High density lipoprotein decreased x x x x x x x x x x x x x x x x x x x x
Myocardial ischaemia x x x x x x x x x x x x x x x x x x x x
Retrosternal pain x x x x x
Phosphatase alkaline increased x x x x x x
Acute myocardial infarction x x x x x x x x x x x x x x x
Liver injury x x x x
Photosensitivity reaction x x x x x x x x x x x x x x x x x x x x
Lightheadedness
Thinking abnormal x x x x x x x x x x x x x x x x x x x x
Discomfort
Convulsions generalised x
Rash erythematous x x x x x x x x x x x x x x x x x x x x
Cerebration impaired x x x x x x x x x x x x x x x x x x x x
Ankle edema
Peripheral ischaemia x x x x x x x x x x x x x x x x x x x x
Depression aggravated x x x x x x x x x x x x x x x x x x x x
Diabetic
Hepatic congestion x x x x x x x x x x x x x x x
Extrasystoles x x x x x
Anaphylactoid reaction x x x x x x x x x x x x x x x x x x x x
Depressed mood
Ischaemic cardiomyopathy x
Rash maculo-papular x x x x x x x x x x x x x x x x x x x x
Cold hands
Respiratory distress x
Rash psoriaform x x x x x x x x x x x x x x x x x x x
Gastrointestinal pain x x x x x x x x x x x x x x x
Intoxication x
Coldness
Sleep disorder x x x x x x x x x x x x x x x x x x x x
Heart failure signs and symptoms
Unwell
Hypotension symptomatic
Respiration abnormal
Paranoia x x x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

CARVEDILOL

Side effects:68
Source:FDA Structured Product Label

CARVEDILOL

Side effects:69
Source:FDA Structured Product Label

CARVEDILOL

Side effects:73
Source:FDA Structured Product Label

CARVEDILOL

Side effects:76
Source:FDA Structured Product Label

CARVEDILOL

Side effects:76
Source:FDA Structured Product Label

CARVEDILOL

Side effects:76
Source:FDA Structured Product Label

CARVEDILOL

Side effects:78
Source:FDA Structured Product Label

CARVEDILOL

Side effects:78
Source:FDA Structured Product Label

CARVEDILOL

Side effects:80
Source:FDA Structured Product Label

CARVEDILOL

Side effects:81
Source:FDA Structured Product Label

Carvedilol

Side effects:81
Source:FDA Structured Product Label

CARVEDILOL

Side effects:81
Source:FDA Structured Product Label

CARVEDILOL

Side effects:104
Source:FDA Structured Product Label

CARVEDILOL

Side effects:125
Source:FDA Structured Product Label

CARVEDILOL

Side effects:130
Source:FDA Structured Product Label

Carvedilol / CARVEDILOL TABLETS

Side effects:141
Source:medicines.org.au

CARVEDILOL / DOM-CARVEDILOL

Side effects:145
Source:Health Canada

DILATREND / DILATREND

Side effects:145
Source:medicines.org.au

Carvedilol / DicarzTM

Side effects:148
Source:medicines.org.au

CARVEDILOL / APO-CARVEDILOL

Side effects:151
Source:Health Canada

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label